EV-301: A phase III trial in progress evaluating enfortumab vedotin versus chemotherapy in patients with locally advanced or metastatic urothelial carcinoma Meeting Abstract


Authors: Petrylak, D. P.; Rosenberg, J. E.; Lee, J.; Yonese, J.; Duran, I.; Loriot, Y.; Sonpavde, G.; Wu, C.; Gartner, E. M.; Melhem-Bertrandt, A.; Powles, T.
Abstract Title: EV-301: A phase III trial in progress evaluating enfortumab vedotin versus chemotherapy in patients with locally advanced or metastatic urothelial carcinoma
Meeting Title: 2019 ESMO Asia Congress
Journal Title: Annals of Oncology
Volume: 30
Issue: Suppl. 9
Meeting Dates: 2019 Nov 22-24
Meeting Location: Singapore
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2019-11-01
Start Page: ix75
End Page: ix76
Language: English
ACCESSION: WOS:000503487700216
PROVIDER: wos
DOI: 10.1093/annonc/mdz425.014
Notes: Meeting Abstract: 223TiP -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jonathan Eric Rosenberg
    510 Rosenberg